These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9753034)

  • 21. Chemotherapy and bone marrow transplantation for myelodysplastic syndromes.
    Cheson BD
    Semin Oncol; 1992 Feb; 19(1):85-94. PubMed ID: 1736371
    [No Abstract]   [Full Text] [Related]  

  • 22. 5-azacitidine: An alternative treatment of myelodysplastic syndromes in patient with refractory response to hematopoietic growth factor, a case report and review of literatures.
    Suwanawiboon B; Sumida KN
    Hawaii Med J; 2004 Jan; 63(1):14-6, 25. PubMed ID: 15011897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Management of myelodysplastic syndromes].
    Hotta T
    Rinsho Ketsueki; 1990 Apr; 31(4):416-30. PubMed ID: 1696325
    [No Abstract]   [Full Text] [Related]  

  • 24. [Efficiency of GHA priming chemotherapy on patients with refractory acute myeloid leukemia and myelodysplastic syndrome and its relationship with expression of costimulatory molecule B7.1].
    Chen YX; Ma XR; Zhang WG; Liu J; Cao XM; He AL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1002-5. PubMed ID: 18928583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prior hypomethylating agent use lacks impact on clinical outcome in patients with secondary acute myeloid leukemia arising from myelodysplastic syndromes treated with standard induction chemotherapy.
    Subari S; Baidoun F; Hreh M; Patnaik M; Hashmi S; Elliott M; Hogan W; Litzow M; Al-Kali A
    Int J Hematol; 2016 Apr; 103(4):409-15. PubMed ID: 26781617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MDS: practical treatment approaches for physicians and nurses.
    Latsko JM; Stone R; Shadduck RK; Breed C; ;
    Clin Adv Hematol Oncol; 2005 Feb; 3(2):1-7. PubMed ID: 16173150
    [No Abstract]   [Full Text] [Related]  

  • 27. Tuning the rigging before sailing off into the stormy sea of stem cell transplants for patients with myelodysplastic syndromes.
    Steensma DP
    Biol Blood Marrow Transplant; 2012 Aug; 18(8):1145-7. PubMed ID: 22609039
    [No Abstract]   [Full Text] [Related]  

  • 28. Differentiation factors.
    Gabrilove JL
    Semin Oncol; 1986 Jun; 13(2):228-33. PubMed ID: 3520829
    [No Abstract]   [Full Text] [Related]  

  • 29. [9th Antonio Raichs memorial lecture. Myelodysplastic syndromes].
    Giralt M
    Sangre (Barc); 1997 Feb; 42(1):63-71. PubMed ID: 9229805
    [No Abstract]   [Full Text] [Related]  

  • 30. [Diagnosis and therapy of myelodysplastic syndrome].
    Mori H; Kuriyama K
    Nihon Naika Gakkai Zasshi; 1999 Jun; 88(6):997-1002. PubMed ID: 10465941
    [No Abstract]   [Full Text] [Related]  

  • 31. Differentiation therapy.
    Spira AI; Carducci MA
    Curr Opin Pharmacol; 2003 Aug; 3(4):338-43. PubMed ID: 12901941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternatives to conventional or myeloablative chemotherapy in myelodysplastic syndrome.
    Cazzola M
    Int J Hematol; 2000 Aug; 72(2):134-8. PubMed ID: 11039660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myelodysplastic syndromes. Pathogenesis, diagnosis and treatment.
    Noël P; Solberg LA
    Crit Rev Oncol Hematol; 1992; 12(3):193-215. PubMed ID: 1379818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The myelodysplastic syndromes: current approaches to therapy.
    Cheson BD
    Ann Intern Med; 1990 Jun; 112(12):932-41. PubMed ID: 2187393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment options for myelodysplastic syndromes.
    Stone R
    Cancer Control; 2004; 11(6 Suppl):7-10. PubMed ID: 15625531
    [No Abstract]   [Full Text] [Related]  

  • 36. [A clinical trial for homoharringtonine and low-dose cytosine arabinoside combined with G-CSF or GM-CSF to treat the relapsed or refractory acute myeloid leukemia (AML), geriatric AML and advanced myelodysplastic syndromes].
    Xu J; Xu CG; Liu T; Xiang B; Chang H; He C
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 40(1):129-32. PubMed ID: 19292062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiation therapy in myelodysplastic syndromes.
    Morosetti R; Koeffler HP
    Semin Hematol; 1996 Jul; 33(3):236-45. PubMed ID: 8819233
    [No Abstract]   [Full Text] [Related]  

  • 38. Hematopoietic growth factor therapy of myelodysplastic syndromes.
    Arcenas AG; Vadhan-Raj S
    Leuk Lymphoma; 1993; 11 Suppl 2():65-9. PubMed ID: 7510197
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hematopoietic growth factors].
    Fillet G
    Rev Med Liege; 1996 Jan; 51(1):102-6. PubMed ID: 8701118
    [No Abstract]   [Full Text] [Related]  

  • 40. Hemopoietic growth factors in the treatment of acute leukemias and myelodysplastic syndromes.
    Seipelt G; Ganser A; Hoelzer D
    Recent Results Cancer Res; 1991; 121():141-54. PubMed ID: 1857855
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.